Eur J Case Rep Intern Med . Acquired Haemophilia A in Association with Influenza A and Urinary Tract Infection

[tetano]

Eur J Case Rep Intern Med


. 2020 Jun 4;7(9):001678.
doi: 10.12890/2020_001678. eCollection 2020.
Acquired Haemophilia A in Association with Influenza A and Urinary Tract Infection


Felipe Pe?a-Mu?oz ¹ , Ernesto Parras ² , Olga Compan ² , Nora Guti?rrez ² , Celestino Martin ² , Jos? Ram?n Gonz?lez-Porras ¹ , Jose Mar?a Bastida ¹



Affiliations

• PMID: 32908824
• PMCID: PMC7473680
• DOI: 10.12890/2020_001678

Abstract

Acquired haemophilia A (AHA) is a rare autoimmune disorder caused by an autoantibody against any circulating coagulation factor, especially factor VIII (FVIII). The lack of awareness of this condition suggests that diagnosis is a challenge and usually delayed, which leads to suboptimal treatment. Consequently, early diagnosis is mandatory to prevent potentially life-threatening bleeding complications. We present the case of an 85-year-old woman admitted to hospital with symptoms of respiratory infection who 12 hours later developed haematuria which required transfusion. Laboratory assays showed an isolated prolonged aPTT, a moderately reduced FVIII and a high inhibitor titre. Influenza A and Escherichia coli were also identified. Antivirals, antibiotics, immunosuppressive drugs and haemostatic agents were started. Two weeks later, the inhibitor was not detected, and bleeding and symptoms of infection had resolved. Immunosuppressive drugs were stopped on day 45 and there has been no recurrence since then. To date, no FVIII inhibitors have been reported in concomitant infection with influenza A and urinary E. coli. The identification of conditions potentially associated with AHA is essential to achieve complete remission.
Learning points: The lack of awareness of and experience with acquired haemophilia (AHA) suggests that diagnosis is frequently delayed, resulting in suboptimal treatment.AHA should be suspected in recent-onset abnormal bleeding in patients not receiving anticoagulant treatment, and in the presence of isolated prolonged activated partial thromboplastin time (aPTT).Treatment is based on eradication of the inhibitor, control of the bleeding and identification of underlying conditions.

Keywords: Acquired haemophilia; bleeding disorders; infectious diseases; influenza.